APA (7th ed.) Citation

Schiffmann, R., Ries, M., Timmons, M., Flaherty, J. T., & Brady, R. O. (2006). Long-term therapy with agalsidase alfa for Fabry disease: Safety and effects on renal function in a home infusion setting. Nephrology, dialysis, transplantation, 21(2), . https://doi.org/10.1093/ndt/gfi152

Chicago Style (17th ed.) Citation

Schiffmann, Raphael, Markus Ries, Margaret Timmons, John T. Flaherty, and Roscoe Owen Brady. "Long-term Therapy with Agalsidase Alfa for Fabry Disease: Safety and Effects on Renal Function in a Home Infusion Setting." Nephrology, Dialysis, Transplantation 21, no. 2 (2006). https://doi.org/10.1093/ndt/gfi152.

MLA (9th ed.) Citation

Schiffmann, Raphael, et al. "Long-term Therapy with Agalsidase Alfa for Fabry Disease: Safety and Effects on Renal Function in a Home Infusion Setting." Nephrology, Dialysis, Transplantation, vol. 21, no. 2, 2006, https://doi.org/10.1093/ndt/gfi152.